meropenem and Whooping-Cough

meropenem has been researched along with Whooping-Cough* in 1 studies

Other Studies

1 other study(ies) available for meropenem and Whooping-Cough

Article	Year
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to four fluoroquinolones (levofloxacin, d-ofloxacin, ofloxacin, and ciprofloxacin), cefpirome, and meropenem. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:3 The in vitro activities of levofloxacin, ofloxacin, d-ofloxacin, ciprofloxacin, cefpirome, and meropenem against 34 clinical isolates each of Bordetella pertussis and Bordetella parapertussis were determined by agar dilution on Mueller-Hinton agar supplemented with 5% horse blood. Levofloxacin was as active as ciprofloxacin against both species (MIC, 0.06 microgram/ml) and more active than ofloxacin and d-ofloxacin. Cefpirome was more active against B. pertussis (MIC, 1.0 microgram/ml) than against B. parapertussis (MIC, > 2 micrograms/ml), while the reverse was true for meropenem (MIC, 2.0 micrograms/ml against B. pertussis and 1.0 microgram/ml against B. parapertussis). Topics: Anti-Infective Agents; Bordetella; Bordetella Infections; Bordetella pertussis; Cefpirome; Cephalosporins; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Thienamycins; Whooping Cough	1996

Article

Year

In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to four fluoroquinolones (levofloxacin, d-ofloxacin, ofloxacin, and ciprofloxacin), cefpirome, and meropenem.

Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:3

The in vitro activities of levofloxacin, ofloxacin, d-ofloxacin, ciprofloxacin, cefpirome, and meropenem against 34 clinical isolates each of Bordetella pertussis and Bordetella parapertussis were determined by agar dilution on Mueller-Hinton agar supplemented with 5% horse blood. Levofloxacin was as active as ciprofloxacin against both species (MIC, 0.06 microgram/ml) and more active than ofloxacin and d-ofloxacin. Cefpirome was more active against B. pertussis (MIC, 1.0 microgram/ml) than against B. parapertussis (MIC, > 2 micrograms/ml), while the reverse was true for meropenem (MIC, 2.0 micrograms/ml against B. pertussis and 1.0 microgram/ml against B. parapertussis).

Topics: Anti-Infective Agents; Bordetella; Bordetella Infections; Bordetella pertussis; Cefpirome; Cephalosporins; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Thienamycins; Whooping Cough

1996